Procept BioRobotics (PRCT) announced that Larry Wood will join the company as President and CEO effective September 2. Reza Zadno will retire as president, CEO, and director effective September 1. Zadno has led the company since 2020. Wood has more than 40 years of experience in the medical technology industry at both Edwards Lifesciences and Baxter Healthcare Corporation. He is joining Procept BioRobotics from Edwards, where he has served as corporate vice president and group president, Transcatheter Aortic Valve Replacement and Surgical Structural Heart, since 2023. Prior to that, he was corporate vice president, Transcatheter Aortic Valve Replacement and earlier in his career at Edwards, he held key positions in manufacturing management, regulatory affairs and strategic and clinical marketing, primarily in the company’s leading surgical heart valve franchise. In 2024, he joined Procept BioRobotics’ board of directors and is a member of its audit committee.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRCT:
- Procept BioRobotics completes WATER IV trial procedures
- Leerink sees positive readthrough for Procept after CMS’ OPPS proposed rule
- 3 Best Stocks to Buy Now, 7/16/2025, According to Top Analysts
- Procept BioRobotics price target lowered to $68 from $71 at Morgan Stanley
- Positive Outlook on PROCEPT BioRobotics Amid New Fee Schedule Developments for Aquablation